https://www.pharmanow.live/latest-news/ema-womens-health-regulatory-roadmap-q4-2026 2026-09-30T21:52:24+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 EMA Sets Deadline for Women's Health Regulatory Roadmap After Amsterdam Workshop EMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0a492441-abd0-43bc-9bf0-9b10fcc49dea/fe2c3503-fdca-44d5-ad35-0607fc29721e.png https://www.pharmanow.live/latest-news/abbvie-abbv-295-phase-1-amylin-analog-monthly-dosing-easd-2026 2026-09-30T21:51:08+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 AbbVie Achieves Phase 1 Milestone for ABBV-295 Amylin Analog Supporting Monthly Dosing Intervals AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0a492441-abd0-43bc-9bf0-9b10fcc49dea/9ca842fe-112d-41f1-8dbe-df96b9ecc5f0.png https://www.pharmanow.live/latest-news/roche-fda-priority-review-fenebrutinib-rms-ppms 2026-09-30T13:41:56+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 Roche's Fenebrutinib Gets FDA Priority Review For RMS And PPMS Roche https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/5484c9ba-4f73-43ef-9a58-42efd650ec5a/19a67fd0-3ce6-4f3c-81a1-027aac7fc76a.png https://www.pharmanow.live/latest-news/abbvie-zumilokibart-phase-2-apex-part-b-atopic-dermatitis-phase-3 2026-09-30T13:43:25+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 AbbVie's Zumilokibart Hits Phase 2 Endpoint For Atopic Dermatitis AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/5484c9ba-4f73-43ef-9a58-42efd650ec5a/fe5caeb9-dce1-4c57-baa3-0cfd31235df1.png https://www.pharmanow.live/latest-news/astrazeneca-secures-stake-summit-therapeutics-2-billion-ivonescimab-deal 2026-09-30T11:28:25+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 AstraZeneca Secures 12% Stake In Summit For $2B Ivonescimab Asset AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/ad22730d-e49e-4d5a-8c17-31bcc8b24100/64423135-3255-4504-82f4-6566a6964329.png https://www.pharmanow.live/latest-news/lilly-foundayo-outperforms-oral-semaglutide-weight-loss-indirect-achieve-3-analysis 2026-09-30T11:27:05+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 Lilly Foundayo Outperforms Oral Semaglutide In Weight Loss Trials Lilly https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/ad22730d-e49e-4d5a-8c17-31bcc8b24100/632e5399-9316-4749-bf2a-f32b65132b5f.png https://www.pharmanow.live/latest-news/novo-nordisk-hengrui-oral-glp-1-deal-2-6-billion 2026-09-30T11:25:31+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 Novo Nordisk Signs $2.6 Billion Deal with Hengrui for Oral GLP-1 Candidate Novo Nordisk https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/ad22730d-e49e-4d5a-8c17-31bcc8b24100/02b0109b-4dee-471e-81d6-30ee7e3be0b4.png https://www.pharmanow.live/latest-news/fda-crcg-lai-generics-workshop-december-2026-anda-submission 2026-09-30T11:22:26+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 FDA & CRCG Host December 2026 LAI Generics Workshop On ANDA Gaps FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/7fb33c23-fd7b-4954-9cd5-fb1c768dbffe/948ca2b0-fc05-4b68-b1d1-b89d593f4334.png https://www.pharmanow.live/latest-news/fda-charges-indian-nationals-counterfeit-ozempic-distribution-scheme 2026-09-30T11:19:36+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 FDA Charges Two Indian Nationals In Fake Ozempic Ring FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/7fb33c23-fd7b-4954-9cd5-fb1c768dbffe/3a4546a3-6766-4e2d-ad9d-bb335eec778b.png https://www.pharmanow.live/latest-news/telix-fda-fast-track-bipass-pre-biopsy-prostate-cancer-pet 2026-09-30T11:19:33+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 Telix Secures FDA Fast Track For BiPASS Prostate Cancer Program Telix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/7fb33c23-fd7b-4954-9cd5-fb1c768dbffe/e90f84a3-55b4-4cdb-a80a-bf803e26320e.png https://www.pharmanow.live/latest-news/zealand-pharma-zupreme-1-phase-2-petrelintide-weight-loss-results 2026-09-30T11:19:28+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 Zealand Petrelintide Hits Double Digit Weight Loss In Phase Two Zealand Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/7fb33c23-fd7b-4954-9cd5-fb1c768dbffe/33d03559-8f50-4043-b751-0a23e7955a0b.png https://www.pharmanow.live/latest-news/maat-pharma-chmp-rejection-xervyteg-fda-pre-ind-maat034-2026 2026-09-30T11:19:24+05:30 Pharma Now en 2026-09-30T00:00:00+05:30 MaaT Pharma Shifts MaaT034 To FDA Path After Xervyteg EU Rejection Maat Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.maatpharma.com/wp-content/uploads/2021/12/MAAT_emblem_colored_large-e1641229370236.png https://www.pharmanow.live/latest-news/medicus-pharma-submits-seamless-phase-2b3-protocol-fda-teverelix-advanced-prostate-cancer 2026-09-30T12:00:47+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Medicus Pharma Submits Phase 2b/3 Teverelix Protocol to FDA Medicus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/medicus-pharma-fda-phase-2b3-teverelix-advanced-prostate-cancer20260930120033.webp https://www.pharmanow.live/latest-news/fresenius-kabi-fda-warning-letter-aseptic-processing-melrose-park-2026 2026-09-30T11:59:07+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Fresenius Kabi Receives FDA Warning Letter After Aseptic Processing Investigation Failures at Melrose Park Facility FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fresenius-kabi-fda-warning-letter-aseptic-processing-melrose-park-202620260930115853.webp https://www.pharmanow.live/latest-news/celmade-fda-warning-letter-unapproved-botulinum-toxin-2026 2026-09-30T11:55:10+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Celmade Receives FDA Warning Letter for Unapproved Injectable Botulinum Toxin Sales into U.S. Celmade https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bentley-laboratories-fda-cgmp-warning-letter-202620260930115334.webp https://www.pharmanow.live/latest-news/bentley-laboratories-fda-cgmp-warning-letter-2026 2026-09-30T11:46:56+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Bentley Laboratories Receives FDA CGMP Warning Letter Citing OOS Investigation Failures and Unapproved Drugs https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bentley-laboratories-fda-cgmp-warning-letter-202620260930114651.webp https://www.pharmanow.live/latest-news/akums-dcgi-approval-colchicine-cardiovascular-india-first 2026-09-30T11:43:05+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Akums Gains DCGI Approval for Colchicine in Cardiovascular Indication, a First in India Akums https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/akums-dcgi-approval-colchicine-cardiovascular-india-first20260930114253.webp https://www.pharmanow.live/latest-news/pfizer-45-oncology-studies-esmo-2025-madrid 2026-09-30T11:36:14+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Pfizer Takes 45 Oncology Studies to ESMO 2025 Congress in Madrid Across Oral and Poster Sessions Pfizer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/pfizer-45-oncology-studies-esmo-2025-madrid20260930113610.webp https://www.pharmanow.live/latest-news/abbvie-fda-approval-juvmo-parkinsons-disease-d1-d5-agonist 2026-09-30T11:29:04+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 AbbVie Wins FDA Approval for JUVMO in Parkinson's Disease AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie-fda-approval-juvmo-parkinsons-disease-d1-d5-agonist20260930112848.webp https://www.pharmanow.live/latest-news/phathom-pharmaceuticals-initiates-phase-3-vonoprazan-as-needed-nerd 2026-09-30T11:26:55+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Phathom Launches Phase 3 Vonoprazan Trial for GERD Phathom https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/phathom-pharmaceuticals-phase-3-vonoprazan-as-needed-nerd20260930112642.webp https://www.pharmanow.live/latest-news/moleculin-biotech-completes-part-a-enrollment-miracle-trial-aml-q1-2027 2026-09-30T11:24:42+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Moleculin Biotech Achieves Full Part A Enrollment in Phase 2/3 AML MIRACLE Trial Moleculin https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/moleculin-biotech-miracle-trial-aml-part-a-enrollment-q1-202720260930112438.webp https://www.pharmanow.live/latest-news/epicur-pharma-fda-warning-letter-misbranded-compounded-animal-drugs-2026 2026-09-30T11:20:01+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Epicur Pharma Receives FDA Warning Letter Over Misbranded Compounded Animal Drug Claims Epicur https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/epicur-pharma-fda-warning-letter-misbranded-compounded-animal-drugs-202620260930111955.webp https://www.pharmanow.live/latest-news/abbvie-signs-ai-collaboration-valkai-accelerate-clinical-development-timelines 2026-09-30T11:18:00+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 AbbVie Partners With Valkai to Accelerate Clinical Development AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie-valkai-ai-collaboration-clinical-development-timelines-202620260930111754.webp https://www.pharmanow.live/latest-news/propanc-biopharma-gmp-manufacture-regulatory-phase-1b-prp-trial-2027 2026-09-30T11:13:29+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Propanc Biopharma Advances GMP Manufacture and Regulatory Workstreams Propanc https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/propanc-biopharma-gmp-manufacture-regulatory-phase-1b-prp-trial-202720260930111320.webp https://www.pharmanow.live/latest-news/newamsterdam-pharma-spinoza-trial-first-participant-preclinical-alzheimers 2026-09-30T11:11:09+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial for Preclinical Alzheimer's Disease NewAmsterdam https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/newamsterdam-pharma-spinoza-trial-first-participant-preclinical-alzheimers20260930111101.webp https://www.pharmanow.live/latest-news/fibrobiologics-secures-european-patent-fibroblast-conditioning-spinal-disc-regeneration 2026-09-30T11:03:01+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 FibroBiologics Secures European Patent for Fibroblast Conditioning Methods Covering Spinal Disc Regeneration FibroBiologics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fibrobiologics-european-patent-fibroblast-conditioning-spinal-disc-regeneration20260930110248.webp https://www.pharmanow.live/latest-news/kellin-chemicals-adulteration-designation-fda-inspection-refusal-zhangjiagang 2026-09-30T10:58:18+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Kellin Chemicals Gains Adulteration Designation After Refusing FDA Facility Inspection in Zhangjiagang Kellin https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/kellin-chemicals-adulteration-designation-fda-inspection-refusal-zhangjiagang20260930105807.webp https://www.pharmanow.live/latest-news/curia-new-york-fda-warning-letter-undocumented-chromatographic-injections-2026 2026-09-30T10:54:48+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Curia New York Receives FDA Warning Letter Over Thousands of Undocumented Chromatographic Injections https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/curia-new-york-fda-warning-letter-undocumented-chromatographic-injections-202620260930105432.webp https://www.pharmanow.live/latest-news/ab-science-revises-clinical-trial-timelines-for-cause-gcp-inspection 2026-09-29T18:44:13+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Ab Science Revises Trial Timelines After Three Gcp Inspections Ab Science https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ab-science-cause-gcp-inspection-clinical-trial-timelines-202620260929184005.webp https://www.pharmanow.live/latest-news/novo-nordisk-hengrui-pharma-license-hrs-1596-oral-glp1-gip-agonist 2026-09-29T18:32:53+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Novo Nordisk Signs $2.6B Deal With Hengrui For Oral GLP-1 Novo Nordisk https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-hengrui-pharma-hrs-1596-oral-glp1-gip-agonist20260929183200.webp https://www.pharmanow.live/latest-news/teva-fda-approval-degevma-denosumab-biosimilar-xgeva 2026-09-29T18:25:52+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Teva Wins FDA Nod For DEGEVMA, Completing Denosumab Portfolio Teva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/teva-fda-approval-degevma-denosumab-biosimilar-xgeva20260929182504.webp https://www.pharmanow.live/latest-news/boothwyn-pharmacy-fda-warning-letter-sterility-potency-failures-2026 2026-09-29T18:21:52+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 FDA Warns Boothwyn Pharmacy Over Sterility, Potency Issues FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/boothwyn-pharmacy-fda-warning-letter-sterility-potency-failures-202620260929182105.webp